PSI CRO We are a leading full-service global CRO specializing in clinical drug development. Our company was founded in 1995 and is incorporated in Zug, Switzerland. Our key strength is fast and predictable patient enrollment across multiple therapeutic areas. 90% of studies that the company manages complete patient enrollment either on or ahead of schedule. We invest substantial effort and MD resource into performing feasibility assessments that play a key role in ensuring predictability of study timelines. The company has global capabilities including the USA and Western Europe, but is particularly distinguished by a solid presence, well-established infrastructure and in-depth experience in the fast-enrolling countries of Central & Eastern Europe and Latin America. By placing a significant number of sites in these high-enrolling territories we are certain to meet global patient enrollment timelines in clinical trials of varying sizes and levels of complexity. The company has developed a unique methodology for managing global registration phase III studies allowing for fast and predictable patient enrollment across a broad range of indications. As a result of our thorough feasibility assessments we are in an excellent position to guarantee study timelines, allowing our sponsors to be as confident in our abilities as we are.